Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
884.8500
6.20
(
0.71
%)
NSE
May 12, 2025
15:31 PM
33.18% Fall from 52W High
Volume:
695.7K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
02 Jan 2023
US FDA Approval
884.85
0.71%
Ashika - Stock Picks Zydus Lifesciences Ltd. - January 2023
Buy:
Zydus Lifesciences Ltd.
by
Ashika Research
Target: 480
Ashika Research
Zydus Lifesciences Ltd. is trading
above its 50 day SMA
of 882.3
More from Zydus Lifesciences Ltd.
Recommended
Which stocks did superstar investors buy in Q4FY25?
The Baseline |
12 May 2025, 04:25PM
Market closes higher, Triveni Turbine's Q4 net profit grows 23.6% YoY to Rs 93.9 crore
Trendlyne Marketwatch |
12 May 2025, 04:03PM
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020